A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors

Clinical trial NCT05378178 · UNKNOWN

Trial details

NCT number: NCT05378178
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-06-08
Primary completion: 2023-12-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.